Integrating eSAGE With EHR Data Using Machine Learning for the Early Detection and Monitoring of Cognitive Impairment in Individuals

Enrolling by invitationOBSERVATIONAL
Enrollment

1,486

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
DementiaAlzheimer DiseaseMild Cognitive ImpairmentWorried Well
Interventions
DIAGNOSTIC_TEST

electronic self administered gerocognitive examination (eSAGE)

A self-administered digital assessment that evaluates multiple cognitive domains: orientation, language, memory, executive function, calculations, abstraction, and visuospatial abilities, through multiple questions. Additionally, it includes the collection of six clinical variables: education, gender, race, family history of dementia, stroke, and emotion.

Trial Locations (1)

43123

Nicole Vrettos, Columbus

All Listed Sponsors
lead

Douglas Scharre

OTHER